NVAX

Novavax, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website novavax.com
Employees(FY) 1992
ISIN US6700024010

Performance

-11.15%

+7.0%

-13.77%

-30.45%

+5.53%

YTD

+112.12%

Profile

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Advanced Technical Analysis

Technical Analysis of NVAX 2025-01-31

The stock indicators suggest a predominantly bearish sentiment, with a Moving Average Score of 3 indicating strong bearish momentum, while the Oscillators Score of 40 reflects a neutral stance. However, the Technical Score of 9 reinforces the overall bearish outlook, signaling caution for potential investors.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of NVAX

Stock Rank

Recent News & Updates

2025-01-27 17:45
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know(Zacks)
2025-01-24 10:50
Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots(Investor's Business Daily)
2025-01-22 09:55
Wall Street Analysts Predict an 81.61% Upside in Novavax (NVAX): Here's What You Should Know(Zacks)
2025-01-22 09:00
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It(Zacks)
2025-01-20 22:04
Novavax, Inc. (NVAX) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025(Insider Monkey)
2025-01-16 19:00
Here's How Donald Trump Could Shake Up Health Care And Biotech Stocks(Yahoo Finance)
2025-01-15 17:45
Novavax (NVAX) Rises But Trails Market: What Investors Should Know(Zacks)
2025-01-08 16:03
Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus(Yahoo Finance)
2025-01-08 09:13
Moderna stock seesaws as first US bird flu death puts vaccine development in focus(Yahoo Finance)
2025-01-08 09:00
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know(Zacks)
2025-01-08 08:47
Novavax (NASDAQ:NVAX) surges 35% this week, taking five-year gains to 171%(Simply Wall St.)
2025-01-08 06:52
Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death(Zacks)
2025-01-07 20:13
Moderna stock on track for 10% weekly gain after US bird flu death(Yahoo Finance)
2025-01-07 17:09
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength?(Yahoo Finance)
2025-01-07 12:23
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike(Investor's Business Daily)
2025-01-07 11:26
Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand(GuruFocus.com)
2024-12-24 09:00
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It(Zacks)
2024-12-13 08:29
Novavax Hits First Milestone in Sanofi Partnership, Secures $50 Million Payment(MT Newswires)
2024-12-13 08:00
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone(PR Newswire)
2024-12-12 19:00
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone(Prnewswire)
2024-12-12 11:30
Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?(Zacks)
2024-12-12 08:09
Institutional investors control 53% of Novavax, Inc. (NASDAQ:NVAX) and were rewarded last week after stock increased 6.3%(Simply Wall St.)
2024-12-12 04:34
Sanofi’s combo vaccines gain FDA fast track designation(Pharmaceutical Technology)
2024-12-11 10:25
FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates(Zacks)
2024-12-11 07:50
NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines(Zacks)
2024-12-10 09:00
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know(Zacks)
2024-12-10 08:00
Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza(PR Newswire)
2024-12-09 19:00
Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza(Prnewswire)
2024-12-09 07:08
Lightning Round: UPS is still too expensive going into holidays, says Jim Cramer(Youtube)
2024-12-05 11:54
Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200M(Zacks)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.